OTCMKTS:OCPNY - OLYMPUS Corp/S Stock Price, News, & Analysis

Get Started

$38.73 -0.64 (-1.63 %)

(As of 09/21/2018 04:00 PM ET)

Previous Close$38.73

Today's Range$38.71 - $38.94

52-Week Range$33.66 - $41.87

Volume10,809 shs

Average Volume8,615 shs

Market Capitalization$13.49 billion

P/E Ratio25.65

Dividend Yield0.50%

Beta0.83

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. The company operates through four segments: Medical Business, Scientific Solutions Business, Imaging Business, and Others. It offers endoscopic video imaging systems, gastrointestinal/colono/duodeno/broncho endoscopes, endoscopic ultrasound systems, ultrasound endoscopes/probes, ultrasound centers, capsule endoscopy systems, integrated documentation systems, therapeutic equipment, and ancillary products, as well as cleaning, disinfecting, and sterilization systems; endoscopy products for gastroenterological surgery, bronchial surgery, urology, gynecology, orthopedic surgery, neurosurgery, and anesthesiology, as well as ear, nose, and throat; and therapeutic and surgical equipment, endoscope ancillary equipment, and endotherapy devices. The company also provides biological microscopes systems, such as upright, polarizing, inverted, laser scanning confocal, stereo, and marco fluorescence microscopes, as well as microscope digital cameras, life science imaging software, bio-imaging systems, and virtual slide systems; metallurgical, semiconductor and flat-panel display inspection, laser scanning, and measuring microscopes, as well as microscopic 3D measurement instruments, and industrial microscope ancillary equipment; and industrial videoscopes and fiberscopes, industrial rigidscopes, ultrasonic flaw detectors, eddy current and phased array flaw detectors, and X-ray fluorescence and X-ray diffraction analyzers. In addition, it offers interchangeable lens cameras, compact digital cameras, digital camera accessories, lens barrels units, optical components, digital audio recorders, and binoculars, as well as related software applications; and biomedical materials and conducts system. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

Receive OCPNY News and Ratings via Email

Sign-up to receive the latest news and ratings for OCPNY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Structural clay products

Sub-IndustryN/A

SectorMedical

SymbolOTCMKTS:OCPNY

CUSIPN/A

Webwww.olympus-global.com

Phone813-3340-2427

Debt

Debt-to-Equity Ratio0.40

Current Ratio1.74

Quick Ratio1.25

Price-To-Earnings

Trailing P/E Ratio25.65

Forward P/E Ratio35.86

P/E Growth2.95

Sales & Book Value

Annual Sales$7.10 billion

Price / Sales1.87

Cash Flow$2.9815 per share

Price / Cash12.99

Book Value$11.69 per share

Price / Book3.31

Profitability

EPS (Most Recent Fiscal Year)$1.51

Net Income$515.29 million

Net Margins3.74%

Return on Equity6.82%

Return on Assets3.07%

Miscellaneous

EmployeesN/A

Outstanding Shares342,690,000

Market Cap$13.49 billion

OLYMPUS Corp/S (OTCMKTS:OCPNY) Frequently Asked Questions

What is OLYMPUS Corp/S's stock symbol?

OLYMPUS Corp/S trades on the OTCMKTS under the ticker symbol "OCPNY."

How were OLYMPUS Corp/S's earnings last quarter?

OLYMPUS Corp/S (OTCMKTS:OCPNY) released its quarterly earnings data on Tuesday, August, 7th. The company reported ($0.45) earnings per share for the quarter, missing analysts' consensus estimates of $0.13 by $0.58. The company had revenue of $1.66 billion for the quarter, compared to analyst estimates of $1.60 billion. OLYMPUS Corp/S had a return on equity of 6.82% and a net margin of 3.74%. View OLYMPUS Corp/S's Earnings History.

When is OLYMPUS Corp/S's next earnings date?

OLYMPUS Corp/S is scheduled to release their next quarterly earnings announcement on Wednesday, November, 14th 2018. View Earnings Estimates for OLYMPUS Corp/S.

Who are some of OLYMPUS Corp/S's key competitors?

Some companies that are related to OLYMPUS Corp/S include Express Scripts (ESRX), Illumina (ILMN), Boston Scientific (BSX), Humana (HUM), Vertex Pharmaceuticals (VRTX), HCA Healthcare (HCA), Zoetis (ZTS), Regeneron Pharmaceuticals (REGN), Baxter International (BAX), BEXIMCO PHARMAC/S GDR REGS (BXP), FRESENIUS SE &/S (FSNUY), ASTELLAS PHARMA/ADR (ALPMY), Takeda Pharmaceutical (TKPYY), Fresenius Medical Care AG & Co. (FMS) and Edwards Lifesciences (EW).

Who are OLYMPUS Corp/S's key executives?

OLYMPUS Corp/S's management team includes the folowing people:

Mr. Hiroyuki Sasa, Pres & Representative Director (Age 63)
Mr. Yasuo Takeuchi, VP, CFO, Chief Regional Representative Officer & Director (Age 61)
Mr. Haruo Ogawa, Sr. Exec. Managing Officer, CTO, Head of R&D Group & Director (Age 61)
Mr. Kiichi Hirata, Exec. Managing Officer, Chief Admin. Officer & Director (Age 61)
Ms. Donna Miller, Head of HQ Legal and Global Gen. Counsel

Has OLYMPUS Corp/S been receiving favorable news coverage?

Media stories about OCPNY stock have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research firm identifies positive and negative news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. OLYMPUS Corp/S earned a news impact score of 0.18 on Accern's scale. They also assigned news headlines about the company an impact score of 46.57 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days. View Recent Headlines for OLYMPUS Corp/S.

How do I buy shares of OLYMPUS Corp/S?

Shares of OCPNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is OLYMPUS Corp/S's stock price today?

One share of OCPNY stock can currently be purchased for approximately $38.73.

How big of a company is OLYMPUS Corp/S?

OLYMPUS Corp/S has a market capitalization of $13.49 billion and generates $7.10 billion in revenue each year. The company earns $515.29 million in net income (profit) each year or $1.51 on an earnings per share basis.

How can I contact OLYMPUS Corp/S?

OLYMPUS Corp/S's mailing address is SHINJUKU MONOLITH 3-1 NISHI-SHINJUKU 2-CHOME, SHINJUKU-KU TOKYO M0, 163-0914. The company can be reached via phone at 813-3340-2427 or via email at [email protected]

MarketBeat Community Rating for OLYMPUS Corp/S (OTCMKTS OCPNY)

Community Ranking:		2.2 out of 5 ( )
Outperform Votes:		98 (Vote Outperform)
Underperform Votes:		125 (Vote Underperform)
Total Votes:		223

MarketBeat's community ratings are surveys of what our community members think about OLYMPUS Corp/S and other stocks. Vote "Outperform" if you believe OCPNY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OCPNY will underperform the S&P 500 over the long term. You may vote once every thirty days.

This page was last updated on 9/22/2018 by MarketBeat.com Staff

Featured Article: Trading Strategy Methods and Types